First Interstate Bank’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$5.31M Sell
33,970
-493
-1% -$63.4K 0.71% 26
2020
Q3
$3.94M Sell
34,463
-1,914
-5% -$206K 0.59% 35
2020
Q2
$4.08M Buy
36,377
+1,326
+4% +$141K 0.56% 37
2020
Q1
$3.15M Buy
35,051
+35,036
+233,573% +$3.44M 0.79% 36
2019
Q4
$2K Hold
15
﹤0.01% 525
2019
Q3
$1K Buy
15
+6
+67% +$676 ﹤0.01% 597
2019
Q2
$1K Sell
9
-6
-40% -$773 ﹤0.01% 630
2019
Q1
$2K Buy
+15
New +$1.86K ﹤0.01% 652
2016
Q3
Sell
-915
Closed -$107K 792
2016
Q2
$107K Sell
915
-25
-3% -$3.55K 0.02% 254
2016
Q1
$131K Hold
940
0.03% 226
2015
Q4
$179K Sell
940
-880
-48% -$154K 0.04% 200
2015
Q3
$285K Buy
+1,820
New +$332K 0.06% 168

Other funds holding ALXN

First Interstate Bank's ALXN Position: Q4 2020 in Review

First Interstate Bank reduced its Alexion Pharmaceuticals (ALXN) stake by 1.4% in Q4 2020, selling an estimated $63.4K and leaving 33,970 shares worth $5.31M. The position accounts for 0.71% of the portfolio, ranked #26.

First Interstate Bank first reported a position in ALXN in Q3 2015 and has held it in 12 quarters since. 827 funds tracked by Wall St. Rank hold ALXN as of Q4 2020.

  • First Interstate Bank held 33,970 shares of Alexion Pharmaceuticals worth $5.31M as of Q4 2020.
  • First Interstate Bank sold 493 Alexion Pharmaceuticals shares in Q4 2020, an estimated $63.4K.
  • Alexion Pharmaceuticals made up 0.71% of First Interstate Bank's portfolio in Q4 2020, its #26 holding.
  • First Interstate Bank first reported a position in Alexion Pharmaceuticals in Q3 2015 and has held it in 12 quarters since.
  • 827 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2020.

Based on First Interstate Bank's 13F filing for Q4 2020, filed 3 Feb 2021.